Additional effects of HERV reactivation in tumor tissues are represented by T-cell infiltration, as well as upregulation of immune checkpoints, including programmed cell death-1 (PD-1) and cytotoxic T-cell-associated protein 4 (CTLA-4) [25]. The gene discussed is PDCD1; the disease is neoplasm.